Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × acalabrutinib × 1 year × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 41 Lymphoma, Mantle-Cell 20 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma 7 Lymphoma, Non-Hodgkin 6 Waldenstrom Macroglobulinemia 4 Lymphoma, B-Cell 3 Leukemia, B-Cell 3 Leukemia 3 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Prolymphocytic 2 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Part1: Advanced B-cell Malignancies 1 Neuritis 1 Neoplasm, Residual 1 Multiple Myeloma 1 Lymphatic Diseases 1 Leukemia, Hairy Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Heart Failure 1 Glioblastoma 1 Chromosome 17 deletion 1 Cardiovascular Diseases 1 Burkitt Lymphoma 1 Anemia, Hemolytic, Autoimmune 1

Interventions

pembrolizumab 119 Cisplatin 70 Cetuximab 52 Carboplatin 46 Nivolumab 39 Paclitaxel 38 Docetaxel 33 Radiotherapy 32 Radiotherapy, Intensity-Modulated 23 Fluorouracil 19 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Taxes 11 durvalumab 10 cemiplimab 10 Radiation 10 Platinum 10 Ipilimumab 10 1,2-diaminocyclohexaneplatinum II citrate 10 atezolizumab 9 Drug Therapy 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Surgical Procedures, Operative 7 Standard of Care 7 Chemoradiotherapy 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 toripalimab 6 avelumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡